CliffBio
small molecule

PONSTEL

MEFENAMIC ACID

Loss of exclusivity—loss of exclusivity
CompanyAvion Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand namePONSTEL
Active ingredientMEFENAMIC ACID
Strength250MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
Marketing statusRX

More from Avion Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PONSTEL patent cliff — loss of exclusivity — | CliffBio